Cumberland Pharmaceuticals, Inc. (CPIX)
8.49
+0.01
(+0.12%)
USD |
NASDAQ |
Oct 23, 16:00
7.48
-1.01
(-11.90%)
After-Hours: 20:00
Cumberland Pharmaceuticals Price to Book Value : 7.295 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 7.295 |
| October 22, 2026 | 7.286 |
| October 21, 2026 | 7.020 |
| October 20, 2026 | 6.839 |
| October 19, 2026 | 5.757 |
| October 16, 2026 | 6.169 |
| October 15, 2026 | 6.479 |
| October 14, 2026 | 6.436 |
| October 13, 2026 | 6.161 |
| October 12, 2026 | 6.015 |
| October 09, 2026 | 6.040 |
| October 08, 2026 | 5.997 |
| October 07, 2026 | 5.920 |
| October 06, 2026 | 6.135 |
| October 05, 2026 | 6.092 |
| October 02, 2026 | 6.350 |
| October 01, 2026 | 6.453 |
| September 30, 2026 | 6.728 |
| September 29, 2026 | 6.573 |
| September 28, 2026 | 6.633 |
| September 25, 2026 | 6.539 |
| September 24, 2026 | 6.882 |
| September 23, 2026 | 6.822 |
| September 22, 2026 | 7.046 |
| September 21, 2026 | 6.522 |
| Date | Value |
|---|---|
| September 18, 2026 | 6.290 |
| September 17, 2026 | 6.178 |
| September 16, 2026 | 5.997 |
| September 15, 2026 | 5.705 |
| September 14, 2026 | 5.757 |
| September 11, 2026 | 5.490 |
| September 10, 2026 | 5.568 |
| September 09, 2026 | 5.404 |
| September 08, 2026 | 5.688 |
| September 04, 2026 | 5.834 |
| September 03, 2026 | 5.800 |
| September 02, 2026 | 5.602 |
| September 01, 2026 | 5.636 |
| August 31, 2026 | 5.748 |
| August 28, 2026 | 7.269 |
| August 27, 2026 | 7.432 |
| August 26, 2026 | 7.707 |
| August 25, 2026 | 7.475 |
| August 24, 2026 | 6.736 |
| August 21, 2026 | 6.573 |
| August 20, 2026 | 6.444 |
| August 19, 2026 | 6.573 |
| August 18, 2026 | 6.556 |
| August 17, 2026 | 6.599 |
| August 14, 2026 | 6.693 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.793 |
| Corcept Therapeutics, Inc. | 13.13 |
| Veru, Inc. | 1.346 |
| Johnson & Johnson | 7.789 |
| Eli Lilly & Co. | 35.39 |
Price to Book Value Related Metrics
| PS Ratio | 4.063 |
| PEG Ratio | -0.0481 |
| Price to Free Cash Flow | 203.60 |
| Price | 8.49 |
| Earnings Yield | -8.59% |
| Market Cap | 127.21M |
| PEGY Ratio | -0.0481 |